Pan-cancer analysis of the effect of biopsy site on tumor mutational burden observations
Plain language summary The total number of mutations, or changes, found within the DNA of cancer cells in a tumor sample is known as the tumor mutational burden (TMB). TMB scores have been proposed to be a marker of how well a tumor might respond to immunotherapy, a type of treatment that triggers t...
Guardado en:
Autores principales: | Simon Papillon-Cavanagh, Julia F. Hopkins, Shakti H. Ramkissoon, Lee A. Albacker, Alice M. Walsh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4e897cbc9b7e4b24833e722c9700416e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden
por: Parikh AR, et al.
Publicado: (2018) -
Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds
por: Burair A. Alsaihati, et al.
Publicado: (2021) -
Panels and models for accurate prediction of tumor mutation burden in tumor samples
por: Elizabeth Martínez-Pérez, et al.
Publicado: (2021) -
Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups
por: Yan W. Asmann, et al.
Publicado: (2021) -
Expert Consensus on Tumor Mutational Burden for Immunotherapy in Lung Cancer
por: Chinese Society of Clinical Oncology, Expert Committee on Tumor Vascular-targeted Therapy, et al.
Publicado: (2021)